BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 15955740)

  • 1. Siglecs in innate immunity.
    Crocker PR
    Curr Opin Pharmacol; 2005 Aug; 5(4):431-7. PubMed ID: 15955740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD33-related sialic-acid-binding immunoglobulin-like lectins in health and disease.
    McMillan SJ; Crocker PR
    Carbohydr Res; 2008 Aug; 343(12):2050-6. PubMed ID: 18279844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative regulation of leucocyte functions by CD33-related siglecs.
    Avril T; Attrill H; Zhang J; Raper A; Crocker PR
    Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglecs as positive and negative regulators of the immune system.
    Crocker PR; Redelinghuys P
    Biochem Soc Trans; 2008 Dec; 36(Pt 6):1467-71. PubMed ID: 19021577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Siglecs and their roles in the immune system.
    Crocker PR; Paulson JC; Varki A
    Nat Rev Immunol; 2007 Apr; 7(4):255-66. PubMed ID: 17380156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
    Yousef GM; Ordon MH; Foussias G; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
    Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
    Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD33-related siglecs as potential modulators of inflammatory responses.
    Crocker PR; McMillan SJ; Richards HE
    Ann N Y Acad Sci; 2012 Apr; 1253():102-11. PubMed ID: 22352893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting siglecs--a novel pharmacological strategy for immuno- and glycotherapy.
    Jandus C; Simon HU; von Gunten S
    Biochem Pharmacol; 2011 Aug; 82(4):323-32. PubMed ID: 21658374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Siglec-14, a novel sialic acid receptor undergoing concerted evolution with Siglec-5 in primates.
    Angata T; Hayakawa T; Yamanaka M; Varki A; Nakamura M
    FASEB J; 2006 Oct; 20(12):1964-73. PubMed ID: 17012248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
    Nguyen DH; Ball ED; Varki A
    Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD33-related siglecs on human mononuclear phagocytes, monocyte-derived dendritic cells and plasmacytoid dendritic cells.
    Lock K; Zhang J; Lu J; Lee SH; Crocker PR
    Immunobiology; 2004; 209(1-2):199-207. PubMed ID: 15481154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signalling.
    Crocker PR
    Curr Opin Struct Biol; 2002 Oct; 12(5):609-15. PubMed ID: 12464312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large-scale sequencing of the CD33-related Siglec gene cluster in five mammalian species reveals rapid evolution by multiple mechanisms.
    Angata T; Margulies EH; Green ED; Varki A
    Proc Natl Acad Sci U S A; 2004 Sep; 101(36):13251-6. PubMed ID: 15331780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New I-type lectins of the CD 33-related siglec subgroup identified through genomics.
    Crocker PR; Zhang J
    Biochem Soc Symp; 2002; (69):83-94. PubMed ID: 12655776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
    Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
    J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct endocytic mechanisms of CD22 (Siglec-2) and Siglec-F reflect roles in cell signaling and innate immunity.
    Tateno H; Li H; Schur MJ; Bovin N; Crocker PR; Wakarchuk WW; Paulson JC
    Mol Cell Biol; 2007 Aug; 27(16):5699-710. PubMed ID: 17562860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.